Treats gastroesophageal reflux in adults for 4-12 weeks. Relieves symptoms in diabetic gastroparesis. Not recommended for pediatric patients due to TD risk
Hepatic encephalopathy is altered consciousness due to liver failure. Can occur in both acute and chronic liver disease. Symptoms include movement problems, mood changes, and coma. More than 40% of cirrhosis patients develop hepatic encephalopathy
Rinvoq contains upadacitinib 15mg as an extended-release tablet. Treatment requires TB evaluation and hepatitis screening before initiation. Tablets should be swallowed whole, not split or crushed
Usual adult dose for respiratory tract infections is 250 mg twice daily for 7-14 days. H. pylori treatment requires 500 mg twice daily with amoxicillin and proton-pump inhibitor. Clarithromycin MR should not be used in patients with creatinine clearance <30 mL/min. Food does not affect bioavailability of Clarithromycin MR tablets
Cirrhosis is diffuse liver nodulation due to fibrous bands dividing liver into regenerative nodules. Most common causes are viral hepatitis B/C, alcoholic liver disease, and metabolic fatty liver disease. Cryptogenic cirrhosis accounts for 8-9% of liver transplants in US
Initial dose: 20 mg twice daily for platelets >200 x 10(9)/L. Dose increases in 5 mg increments every 2-4 weeks. Maximum dose: 25 mg twice daily. Treatment should be discontinued after 6 months if no improvement